Trial Profile
Clinical study of sensory evaluation using Olmesartan orally disintegrating tablet (OD tablets) for hypertensive patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2017
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 30 Nov 2015 Status changed from active, no longer recruiting to completed, according to University Hospital Medical Information Network - Japan.
- 02 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 23 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan record.